Profit Or Loss [Abstract]

Zealand Pharma - Filing #1382857

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	103,986,000 EUR	—	—	—	—	108,546,000 EUR	—	192,001,000 EUR	—	—
Profit (loss) from operating activities	—	—	837,153,000 EUR	—	—	—	—	784,317,000 EUR	—	626,235,000 EUR	—	—
Finance income	—	—	133,270,000 EUR	—	—	—	—	41,211,000 EUR	—	2,022,000 EUR	—	—
Finance costs	—	—	268,158,000 EUR	—	—	—	—	15,781,000 EUR	—	49,314,000 EUR	—	—
Profit (loss) before tax	—	—	972,041,000 EUR	—	—	—	—	758,887,000 EUR	—	673,527,000 EUR	—	—
Tax expense (income)	—	—	6,431,000 EUR	—	—	—	—	3,949,000 EUR	—	4,814,000 EUR	—	—
Profit (loss) from continuing operations	—	—	965,610,000 EUR	—	—	—	—	754,938,000 EUR	—	668,713,000 EUR	—	—
Profit (loss) from discontinued operations	—	—	236,525,000 EUR	—	—	—	—	263,211,000 EUR	—	178,016,000 EUR	—	—
Profit (loss)	0 EUR	1,202,135,000 EUR	1,202,135,000 EUR	0 EUR	0 EUR	0 EUR	1,018,149,000 EUR	1,018,149,000 EUR	0 EUR	846,729,000 EUR	0 EUR	846,729,000 EUR
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations	—	—	20.90	—	—	—	—	17.61	—	17.43	—	—
Diluted earnings (loss) per share from discontinued operations	—	—	5.12	—	—	—	—	6.14	—	4.64	—	—
Diluted earnings (loss) per share	—	—	26.02	—	—	—	—	23.75	—	22.07	—	—